where clinical endpoints are used (e.g., CIPN severity, skin lightening), findings are mixed and often context-specific
performed a cross-trial analysis using data from clinical trials of GLP-1RAs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER-6 [59], and AMPLITUDE-O), SGLT2is (CANVAS and CREDENCE), and finerenone (FIDELIO-DKD and FIGARO-DKD) to estimate the effects of the triple combination therapy of GLP-1RA, SGLT2i, and finerenone using the actuarial method [60]
Brcic, L., et al
Pereira GC, Piton E, Dos Santos BM, da Silva RM, de Almeida AS, Dalenogare DP, et al
Desvenlafaxine succinate for major depressive disorder
The deep cellular hydration from the IV provides a healthy glow from within, while nutrients like biotin support stronger hair and nails